Nanoviricides Earnings Estimates, EPS & Revenue | AMEX:NNVC

Comments

Nanoviricides Inc Earnings Estimates

NNVCAMEX

Trade with Public

$1.14

-0.04-3.39%

At close: Mar 16, 5:00 PM EST

$1.14

N/A

After Hours: 4:00 PM EST

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Nanoviricides Earnings Estimates, EPS & Revenue | AMEX:NNVC

Nanoviricides (NNVC) is scheduled to report Q3 earnings on May 14, 2026. Analysts estimate EPS of $-0.10 and quarterly revenue of N/A.

In the most recent quarter (Q2), Nanoviricides reported EPS of $-0.11, missing estimates of $-0.10 by 0.10%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Over the last 4 quarters, Nanoviricides has averaged an EPS surprise of 0.36% and a revenue surprise of 0.00%.

Earnings Date

May 14

EPS Estimate

$-0.100

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–

Nanoviricides Earnings History

Analyze the earnings history of Nanoviricides using advanced sorting and filters.

Loading calendar...

Nanoviricides (NNVC) Earnings Per Share

The chart below shows Nanoviricides's reported EPS compared to analyst estimates over recent quarters.

Nanoviricides (NNVC) Revenue

The chart below shows Nanoviricides's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Nanoviricides (AMEX:NNVC) reporting earnings?

Nanoviricides (NNVC) is scheduled to report earnings on May 14, 2026. The last reported earnings were for reported on February 17, 2026 for Q2.

What were the latest earnings per share (EPS) for Nanoviricides (AMEX:NNVC)?

The Actual EPS was $-0.11, which missed the estimate of $-0.10.

What were Nanoviricides’s (AMEX:NNVC) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

Outlook Therapeutics Inc

Barinthus Biotherapeutics PLC

NASDAQ:BRNS

$0.63

-7.97%

Vistagen Therapeutics Inc

NASDAQ:VTGN

$0.63

-0.67%

Tevogen Bio Holdings Inc

Nanoviricides Earnings Estimates, EPS & Revenue | AMEX:NNVC

Nanoviricides (NNVC) is scheduled to report Q3 earnings on May 14, 2026. Analysts estimate EPS of $-0.10 and quarterly revenue of N/A.

In the most recent quarter (Q2), Nanoviricides reported EPS of $-0.11, missing estimates of $-0.10 by 0.10%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Over the last 4 quarters, Nanoviricides has averaged an EPS surprise of 0.36% and a revenue surprise of 0.00%.

Earnings Date

May 14

EPS Estimate

$-0.100

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–